Neonatal Fc Receptor Blocker [EPC]

Neonatal Fc Receptor Blocker [EPC] was reported 4387 times

Drugs of the Neonatal Fc Receptor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 THYMECTOMY 36 0.4091
1 MYASTHENIA GRAVIS CRISIS 471 0.3176
2 VENOUS ANGIOPLASTY 3 0.2500
3 THYMOMA MALIGNANT RECURRENT 3 0.2000
4 PROCEDURAL HEADACHE 74 0.1805
5 MYASTHENIA GRAVIS 841 0.1040
6 ACTIVITIES OF DAILY LIVING ASSESSMENT 2 0.1000
7 BULBAR PALSY 16 0.0578
8 THYMOMA 19 0.0526
9 GASTROSTOMY TUBE REMOVAL 2 0.0400
10 SYMPTOM RECURRENCE 183 0.0306
11 CARDIAC THERAPEUTIC PROCEDURE 2 0.0294
12 CARDIAC DEVICE IMPLANTATION 2 0.0274
13 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 39 0.0271
14 PLASMAPHERESIS 13 0.0249
15 PROCEDURAL DIZZINESS 7 0.0217
16 CAPILLARY NAIL REFILL TEST ABNORMAL 2 0.0192
17 ANGIOGRAM ABNORMAL 2 0.0179
18 POSITIVE AIRWAY PRESSURE THERAPY 5 0.0171
19 ICHTHYOSIS 4 0.0159
20 DEPENDENCE ON RESPIRATOR 6 0.0150
21 MASTICATION DISORDER 40 0.0131
22 DIAPHRAGM MUSCLE WEAKNESS 2 0.0127
23 MECHANICAL VENTILATION 24 0.0126
24 EYELID PTOSIS 125 0.0123
25 ACUTE CARDIAC EVENT 2 0.0116
26 HERPES ZOSTER REACTIVATION 3 0.0115
27 DYSPNOEA AT REST 33 0.0114
28 BLOOD IMMUNOGLOBULIN G DECREASED 27 0.0109
29 EXPOSURE TO EXTREME TEMPERATURE 2 0.0103
30 DROPPED HEAD SYNDROME 4 0.0101
31 PROCEDURAL NAUSEA 8 0.0099
32 RESPIRATORY MUSCLE WEAKNESS 3 0.0093
33 CHOLELITHOTOMY 2 0.0092
34 OPHTHALMIC HERPES ZOSTER 16 0.0089
35 TREATMENT DELAYED 15 0.0087
36 METASTASES TO PLEURA 9 0.0086
37 EYE SYMPTOM 3 0.0084
38 CYANOPSIA 5 0.0083
39 SKIN TURGOR DECREASED 3 0.0077
40 EYELID CYST 2 0.0077
41 IMMUNOGLOBULINS ABNORMAL 2 0.0077
42 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
43 ANTIBODY TEST ABNORMAL 5 0.0069
44 EHLERS-DANLOS SYNDROME 3 0.0065
45 CENTRAL VENOUS CATHETER REMOVAL 3 0.0064
46 MUSCLE DISCOMFORT 5 0.0064
47 MORPHOEA 3 0.0062
48 PROCEDURAL VOMITING 4 0.0062
49 INJECTION SITE EXFOLIATION 4 0.0060
50 PRECANCEROUS CONDITION 4 0.0060
51 ECTROPION 2 0.0059
52 HERPES ZOSTER OTICUS 3 0.0059
53 THERAPY CHANGE 58 0.0059
54 CHOKING 111 0.0057
55 DIVERTICULITIS INTESTINAL PERFORATED 2 0.0056
56 FEEDING TUBE USER 2 0.0055
57 THERAPEUTIC PRODUCT INEFFECTIVE 21 0.0054
58 DIPLOPIA 136 0.0052
59 DIAPHRAGMATIC DISORDER 4 0.0052
60 EYE CONTUSION 11 0.0052
61 DEVICE RELATED THROMBOSIS 5 0.0051
62 ENDOTRACHEAL INTUBATION 14 0.0050
63 PROSTATE CANCER RECURRENT 3 0.0049
64 PANCREATIC NEUROENDOCRINE TUMOUR 3 0.0047
65 COLONIC ABSCESS 4 0.0047
66 CHONDROCALCINOSIS 3 0.0046
67 OXYGEN THERAPY 7 0.0043
68 CANCER SURGERY 4 0.0042
69 PROSTATE INFECTION 4 0.0042
70 DYSLALIA 3 0.0041
71 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
72 ENDOCARDITIS STAPHYLOCOCCAL 2 0.0041
73 AORTIC VALVE REPLACEMENT 5 0.0040
74 HYPOGAMMAGLOBULINAEMIA 25 0.0038
75 OPHTHALMOPLEGIA 6 0.0038
76 HEAT EXHAUSTION 3 0.0037
77 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 3 0.0036
78 INFECTED BITE 3 0.0035
79 VITH NERVE PARALYSIS 4 0.0035
80 TRACHEOSTOMY 5 0.0035
81 POOR VENOUS ACCESS 36 0.0035
82 EPIDIDYMITIS 4 0.0034
83 DOSE CALCULATION ERROR 2 0.0034
84 BLOOD ALBUMIN INCREASED 3 0.0034
85 COLON CANCER STAGE IV 2 0.0034
86 SALIVA ALTERED 3 0.0033
87 CATARRH 3 0.0033
88 LARGE INTESTINE INFECTION 4 0.0033
89 INTERVERTEBRAL DISC OPERATION 4 0.0032
90 MUSCLE FATIGUE 13 0.0031
91 COLOSTOMY 6 0.0031
92 THERAPEUTIC RESPONSE SHORTENED 100 0.0030
93 BLEPHAROSPASM 18 0.0029
94 INTENSIVE CARE 4 0.0028
95 AMYOTROPHIC LATERAL SCLEROSIS 6 0.0028
96 NOROVIRUS INFECTION 4 0.0028
97 WALKING AID USER 18 0.0027
98 WHEELCHAIR USER 12 0.0027
99 CATARACT OPERATION 16 0.0027
100 ESSENTIAL TREMOR 3 0.0027
101 STEROID DIABETES 4 0.0027
102 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
103 NEUROLOGICAL DECOMPENSATION 6 0.0026
104 MULTIPLE-DRUG RESISTANCE 8 0.0026
105 ASTHENOPIA 14 0.0025
106 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
107 DYSARTHRIA 94 0.0025
108 DRUG EFFECT LESS THAN EXPECTED 37 0.0025
109 SHOULDER FRACTURE 4 0.0024
110 ENDOCARDITIS 12 0.0023
111 PHYSICAL DECONDITIONING 6 0.0023
112 HYPERCAPNIA 7 0.0023
113 CENTRAL VENOUS CATHETERISATION 7 0.0023
114 INFUSION SITE BRUISING 5 0.0023
115 ABSCESS DRAINAGE 2 0.0023
116 ENDOCRINE OPHTHALMOPATHY 2 0.0023
117 CATHETER SITE PRURITUS 2 0.0023
118 CARDIAC ABLATION 4 0.0022
119 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
120 IMMUNOGLOBULINS DECREASED 3 0.0022
121 IMMUNOSUPPRESSION 19 0.0022
122 TUNNEL VISION 4 0.0021
123 PERIORBITAL SWELLING 12 0.0021
124 INFUSION SITE EXTRAVASATION 13 0.0021
125 ANIMAL SCRATCH 2 0.0021
126 MUSCULAR WEAKNESS 232 0.0020
127 DYSPHAGIA 192 0.0020
128 HYPOPNOEA 7 0.0020
129 THERAPY NON-RESPONDER 90 0.0020
130 VASCULAR DEVICE INFECTION 9 0.0020
131 DILATED CARDIOMYOPATHY 2 0.0020
132 AUTONOMIC NEUROPATHY 2 0.0020
133 SPINAL FUSION SURGERY 8 0.0020
134 ARTHRODESIS 2 0.0020
135 INSURANCE ISSUE 30 0.0020
136 CHEST INJURY 4 0.0019
137 HYPOTONIA NEONATAL 3 0.0019
138 CARPAL TUNNEL DECOMPRESSION 2 0.0019
139 LOSS OF THERAPEUTIC RESPONSE 6 0.0019
140 THERAPY CESSATION 96 0.0019
141 PARANASAL SINUS DISCOMFORT 7 0.0018
142 INFUSION SITE MASS 2 0.0018
143 IMMOBILE 8 0.0018
144 THYROID MASS 7 0.0018
145 HYPERVOLAEMIA 9 0.0018
146 SYSTEMIC INFECTION 3 0.0018
147 ANTIBODY TEST POSITIVE 3 0.0018
148 DIVERTICULITIS 50 0.0018
149 SPINAL OPERATION 22 0.0018
150 BLOOD FIBRINOGEN DECREASED 2 0.0018
151 THYROIDECTOMY 3 0.0017
152 BLADDER OPERATION 2 0.0017
153 THORACIC VERTEBRAL FRACTURE 5 0.0017
154 BILE DUCT CANCER 2 0.0017
155 SINUS OPERATION 4 0.0017
156 COLON OPERATION 2 0.0017
157 HAEMATOLOGICAL INFECTION 4 0.0016
158 DENTAL CARE 3 0.0016
159 INFUSION SITE PRURITUS 5 0.0016
160 THERAPEUTIC PRODUCT EFFECT DECREASED 70 0.0016
161 REHABILITATION THERAPY 6 0.0015
162 BILIARY OBSTRUCTION 2 0.0015
163 SARS-COV-2 TEST POSITIVE 20 0.0015
164 CARDIAC PACEMAKER INSERTION 9 0.0015
165 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
166 MENINGITIS 10 0.0015
167 SKIN ABRASION 7 0.0015
168 MIGRAINE WITH AURA 4 0.0015
169 VENOUS THROMBOSIS LIMB 3 0.0015
170 DROOLING 10 0.0014
171 CARDIOVERSION 2 0.0014
172 UPPER RESPIRATORY TRACT INFECTION 66 0.0014
173 FACIAL PARESIS 5 0.0014
174 FACIAL PARALYSIS 12 0.0014
175 OESOPHAGEAL STENOSIS 4 0.0014
176 CEREBELLAR HAEMORRHAGE 2 0.0014
177 INFECTION SUSCEPTIBILITY INCREASED 3 0.0014
178 THERAPY INTERRUPTED 97 0.0014
179 URINARY TRACT INFECTION 231 0.0014
180 CHOLANGIOCARCINOMA 2 0.0013
181 LARGE INTESTINAL OBSTRUCTION 3 0.0013
182 IMPETIGO 2 0.0013
183 PULMONARY MASS 20 0.0013
184 SENSITIVITY TO WEATHER CHANGE 7 0.0013
185 NEPHROLITHIASIS 61 0.0013
186 ASTIGMATISM 2 0.0013
187 FACE INJURY 5 0.0013
188 THERAPEUTIC PRODUCT EFFECT DELAYED 6 0.0013
189 LUMBAR VERTEBRAL FRACTURE 6 0.0013
190 COMPRESSION FRACTURE 7 0.0013
191 OVERWEIGHT 7 0.0013
192 EYE ALLERGY 2 0.0013
193 GASTROSTOMY 2 0.0013
194 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
195 ORAL SURGERY 3 0.0013
196 ORTHOPNOEA 4 0.0013
197 CUSHINGOID 4 0.0012
198 PULSE ABNORMAL 3 0.0012
199 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
200 STENT PLACEMENT 10 0.0012
201 AUTOIMMUNE DISORDER 12 0.0012
202 COSTOCHONDRITIS 2 0.0012
203 PHARYNGEAL SWELLING 12 0.0012
204 PULMONARY CONGESTION 16 0.0012
205 INJECTION RELATED REACTION 2 0.0012
206 SPINAL STENOSIS 5 0.0012
207 BACK INJURY 13 0.0012
208 DERMATOMYOSITIS 3 0.0012
209 ENDODONTIC PROCEDURE 3 0.0012
210 HOSPITALISATION 181 0.0012
211 TEMPERATURE INTOLERANCE 12 0.0012
212 CERVICAL SPINAL STENOSIS 2 0.0012
213 HERNIA REPAIR 3 0.0012
214 RESPIRATORY TRACT INFECTION 30 0.0012
215 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
216 PRE-EXISTING CONDITION IMPROVED 7 0.0011
217 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
218 SHOULDER ARTHROPLASTY 3 0.0011
219 PAPILLOEDEMA 5 0.0011
220 SALIVARY HYPERSECRETION 11 0.0011
221 DYSPNOEA EXERTIONAL 41 0.0011
222 EYE OPERATION 5 0.0011
223 UROSEPSIS 10 0.0011
224 TIBIA FRACTURE 5 0.0011
225 IMPATIENCE 2 0.0011
226 PERONEAL NERVE PALSY 6 0.0011
227 RESPIRATORY SYMPTOM 3 0.0011
228 HYPOPROTEINAEMIA 2 0.0011
229 HERPES ZOSTER 60 0.0010
230 VITAMIN B12 DECREASED 3 0.0010
231 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
232 RALES 6 0.0010
233 SPINAL CORD COMPRESSION 4 0.0010
234 COVID-19 180 0.0010
235 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
236 GRIP STRENGTH DECREASED 9 0.0010
237 BRAIN FOG 16 0.0010
238 RESPIRATION ABNORMAL 7 0.0010
239 PNEUMONIA FUNGAL 4 0.0010
240 ASPIRATION 11 0.0010
241 VEIN DISORDER 5 0.0010
242 OROPHARYNGEAL DISCOMFORT 9 0.0010
243 BEDRIDDEN 13 0.0010
244 PROSTATITIS 3 0.0010
245 DIABETIC FOOT 3 0.0010
246 ARTHRITIS BACTERIAL 4 0.0010
247 HYPERPARATHYROIDISM 2 0.0010
248 TALIPES 3 0.0010
249 THERAPY PARTIAL RESPONDER 15 0.0010
250 PNEUMONIA ASPIRATION 24 0.0010
251 BLOOD BLISTER 3 0.0010
252 SPEECH DISORDER 50 0.0010
253 IMMUNODEFICIENCY 14 0.0009
254 PSEUDOMONAS INFECTION 8 0.0009
255 EXOPHTHALMOS 2 0.0009
256 HIP SURGERY 5 0.0009
257 SKIN LACERATION 10 0.0009
258 KNEE OPERATION 9 0.0009
259 COLONOSCOPY 2 0.0009
260 LIGAMENT RUPTURE 4 0.0009
261 ABDOMINAL ABSCESS 4 0.0009
262 CATHETERISATION CARDIAC 4 0.0009
263 GASTROINTESTINAL INFECTION 8 0.0009
264 INFECTIOUS MONONUCLEOSIS 2 0.0009
265 ANAL INCONTINENCE 8 0.0009
266 MITRAL VALVE INCOMPETENCE 10 0.0009
267 SUDDEN CARDIAC DEATH 3 0.0009
268 EYE MOVEMENT DISORDER 6 0.0009
269 IMMUNE THROMBOCYTOPENIA 4 0.0009
270 MUSCLE TWITCHING 20 0.0009
271 EYELID DISORDER 2 0.0009
272 POST PROCEDURAL INFECTION 7 0.0009
273 IMPLANT SITE INFECTION 2 0.0009
274 TONGUE DISORDER 6 0.0008
275 RIB FRACTURE 17 0.0008
276 DYSSTASIA 24 0.0008
277 KIDNEY INFECTION 16 0.0008
278 DENTAL OPERATION 2 0.0008
279 CARTILAGE INJURY 2 0.0008
280 DEVICE INFUSION ISSUE 2 0.0008
281 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 145 0.0008
282 GASTROINTESTINAL TUBE INSERTION 2 0.0008
283 SPINAL FRACTURE 16 0.0008
284 LOSS OF CONTROL OF LEGS 3 0.0008
285 ASTHENIA 296 0.0008
286 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 23 0.0008
287 SEASONAL ALLERGY 11 0.0008
288 CONCUSSION 6 0.0008
289 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
290 ORAL INFECTION 3 0.0008
291 NAIL DISCOLOURATION 3 0.0008
292 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
293 KNEE ARTHROPLASTY 16 0.0008
294 MUSCULOSKELETAL DISCOMFORT 13 0.0008
295 FALL 251 0.0008
296 SEPSIS 84 0.0008
297 ANIMAL BITE 2 0.0007
298 ANAL FISTULA 4 0.0007
299 FOOD POISONING 4 0.0007
300 CYSTITIS HAEMORRHAGIC 3 0.0007
301 STRESS FRACTURE 4 0.0007
302 GALLBLADDER OPERATION 3 0.0007
303 MUSCLE TIGHTNESS 12 0.0007
304 POSTOPERATIVE WOUND INFECTION 5 0.0007
305 CATARACT 44 0.0007
306 RESPIRATORY DISORDER 22 0.0007
307 CELLULITIS 37 0.0007
308 CLUMSINESS 2 0.0007
309 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 52 0.0007
310 JAW DISORDER 4 0.0007
311 HIP ARTHROPLASTY 11 0.0007
312 DEVICE RELATED INFECTION 11 0.0007
313 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
314 MUSCULOSKELETAL CHEST PAIN 11 0.0007
315 MUSCLE ATROPHY 9 0.0007
316 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
317 UTERINE HAEMORRHAGE 3 0.0007
318 ABSCESS LIMB 3 0.0007
319 JOINT INJURY 15 0.0007
320 PRODUCT DISPENSING ISSUE 3 0.0007
321 MICTURITION URGENCY 8 0.0007
322 CYTOKINE RELEASE SYNDROME 14 0.0007
323 TENSION HEADACHE 3 0.0007
324 CORONARY ARTERY BYPASS 4 0.0007
325 LACRIMATION INCREASED 21 0.0007
326 FIBULA FRACTURE 2 0.0007
327 MONOPLEGIA 3 0.0007
328 STRESS CARDIOMYOPATHY 4 0.0007
329 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
330 MOTOR DYSFUNCTION 7 0.0007
331 SLUGGISHNESS 7 0.0007
332 DYSPHONIA 40 0.0007
333 BALANCE DISORDER 59 0.0007
334 LIMB DISCOMFORT 21 0.0007
335 COVID-19 PNEUMONIA 8 0.0007
336 PRODUCTIVE COUGH 32 0.0007
337 WEIGHT FLUCTUATION 7 0.0007
338 ATYPICAL PNEUMONIA 2 0.0007
339 ATRIAL FIBRILLATION 65 0.0007
340 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
341 DISEASE COMPLICATION 3 0.0007
342 MENISCUS INJURY 4 0.0006
343 BRAIN DEATH 2 0.0006
344 RENAL FUNCTION TEST ABNORMAL 3 0.0006
345 SECRETION DISCHARGE 8 0.0006
346 SKIN TIGHTNESS 3 0.0006
347 STAPHYLOCOCCAL INFECTION 21 0.0006
348 INFUSION SITE SWELLING 4 0.0006
349 FOREIGN BODY IN THROAT 2 0.0006
350 COLITIS MICROSCOPIC 3 0.0006
351 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
352 INTENTIONAL DOSE OMISSION 18 0.0006
353 NERVE INJURY 7 0.0006
354 HYPERTENSIVE CRISIS 7 0.0006
355 BILE DUCT STONE 2 0.0006
356 SUBCUTANEOUS ABSCESS 3 0.0006
357 HEAD DISCOMFORT 11 0.0006
358 DECUBITUS ULCER 5 0.0006
359 INTERNAL HAEMORRHAGE 7 0.0006
360 GASTROENTERITIS VIRAL 11 0.0006
361 INJECTION SITE INFECTION 2 0.0006
362 BREATH SOUNDS ABNORMAL 3 0.0006
363 INFUSION SITE HAEMORRHAGE 2 0.0006
364 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
365 CORONAVIRUS INFECTION 4 0.0006
366 SPINAL COMPRESSION FRACTURE 5 0.0006
367 HEAD INJURY 19 0.0006
368 BLOOD IRON DECREASED 7 0.0006
369 BACTERAEMIA 7 0.0006
370 LIMB INJURY 16 0.0006
371 DIABETIC RETINOPATHY 2 0.0006
372 HYPERLIPIDAEMIA 7 0.0006
373 FATIGUE 453 0.0006
374 CERVICAL VERTEBRAL FRACTURE 2 0.0006
375 LYMPHOEDEMA 4 0.0006
376 BASAL CELL CARCINOMA 9 0.0006
377 APHONIA 8 0.0006
378 POST PROCEDURAL COMPLICATION 11 0.0006
379 NECK PAIN 32 0.0006
380 SYRINGE ISSUE 10 0.0006
381 NASOPHARYNGITIS 105 0.0006
382 SPINAL OSTEOARTHRITIS 5 0.0006
383 GAIT INABILITY 19 0.0006
384 LYMPHOPENIA 8 0.0006
385 CYSTITIS 18 0.0006
386 NYSTAGMUS 3 0.0006
387 INFLUENZA 63 0.0006
388 TOOTH EXTRACTION 7 0.0006
389 DYSPNOEA 318 0.0006
390 APPENDICECTOMY 2 0.0006
391 HYPERSOMNIA 16 0.0006
392 GINGIVITIS 3 0.0006
393 INJECTION SITE RASH 17 0.0006
394 BLOOD PRESSURE ABNORMAL 11 0.0006
395 EYE DISORDER 18 0.0005
396 RETINAL DETACHMENT 5 0.0005
397 AMYLASE INCREASED 2 0.0005
398 ARTHROPOD BITE 4 0.0005
399 PNEUMONIA 174 0.0005
400 OXYGEN SATURATION DECREASED 30 0.0005
401 HEMIPARESIS 9 0.0005
402 SQUAMOUS CELL CARCINOMA 5 0.0005
403 COLECTOMY 3 0.0005
404 TOOTH INFECTION 7 0.0005
405 CONTUSION 51 0.0005
406 CATHETER SITE INFECTION 2 0.0005
407 HIP FRACTURE 17 0.0005
408 CHOLECYSTECTOMY 6 0.0005
409 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
410 EXERCISE TOLERANCE DECREASED 3 0.0005
411 ANKLE FRACTURE 8 0.0005
412 EATING DISORDER 11 0.0005
413 ABDOMINAL PAIN LOWER 13 0.0005
414 EPIGASTRIC DISCOMFORT 2 0.0005
415 THERAPEUTIC RESPONSE DECREASED 31 0.0005
416 URINE ODOUR ABNORMAL 3 0.0005
417 BRADYKINESIA 3 0.0005
418 URINARY INCONTINENCE 15 0.0005
419 HOSPICE CARE 5 0.0005
420 PLEURISY 3 0.0005
421 SINUS HEADACHE 3 0.0005
422 HYPERPHAGIA 2 0.0005
423 DEVICE OCCLUSION 7 0.0005
424 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
425 CONDITION AGGRAVATED 151 0.0005
426 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
427 FEEDING DISORDER 10 0.0005
428 DRY THROAT 5 0.0005
429 CHOLANGITIS 3 0.0005
430 INFUSION RELATED REACTION 32 0.0005
431 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
432 THROAT TIGHTNESS 13 0.0005
433 INJECTION SITE DISCOLOURATION 6 0.0005
434 PETECHIAE 5 0.0005
435 PHOTOPHOBIA 9 0.0005
436 SURGERY 28 0.0005
437 BRONCHITIS 35 0.0005
438 SLEEP APNOEA SYNDROME 9 0.0005
439 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
440 INFECTION 68 0.0005
441 LOWER LIMB FRACTURE 9 0.0005
442 INFUSION SITE PAIN 6 0.0005
443 HERNIA 9 0.0005
444 CARDIAC OPERATION 4 0.0005
445 HYPERPROLACTINAEMIA 3 0.0005
446 MUSCLE STRAIN 4 0.0005
447 HYSTERECTOMY 4 0.0005
448 PYELONEPHRITIS 4 0.0005
449 NASAL CONGESTION 27 0.0005
450 SINUSITIS 47 0.0005
451 BACK PAIN 106 0.0005
452 ILLNESS 47 0.0005
453 IMMUNE SYSTEM DISORDER 6 0.0005
454 COLD SWEAT 8 0.0005
455 SKIN INFECTION 5 0.0004
456 INTESTINAL PERFORATION 5 0.0004
457 HEAVY MENSTRUAL BLEEDING 4 0.0004
458 PNEUMOTHORAX 7 0.0004
459 RESPIRATORY TRACT CONGESTION 7 0.0004
460 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
461 MOVEMENT DISORDER 14 0.0004
462 PNEUMONIA BACTERIAL 4 0.0004
463 PERIPHERAL SWELLING 67 0.0004
464 RESPIRATORY DISTRESS 12 0.0004
465 NERVE COMPRESSION 4 0.0004
466 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
467 METASTASES TO LUNG 5 0.0004
468 LARGE INTESTINE PERFORATION 3 0.0004
469 BLOOD PRESSURE INCREASED 66 0.0004
470 BACK DISORDER 7 0.0004
471 POST PROCEDURAL HAEMORRHAGE 5 0.0004
472 ILL-DEFINED DISORDER 26 0.0004
473 DIARRHOEA HAEMORRHAGIC 4 0.0004
474 SKIN REACTION 6 0.0004
475 PAPULE 3 0.0004
476 BLOOD PRESSURE DECREASED 28 0.0004
477 PARALYSIS 6 0.0004
478 SKIN CANCER 9 0.0004
479 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
480 HUMERUS FRACTURE 2 0.0004
481 ATELECTASIS 4 0.0004
482 LOCALISED INFECTION 10 0.0004
483 FAECES SOFT 3 0.0004
484 EAR PAIN 8 0.0004
485 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
486 GASTROENTERITIS 6 0.0004
487 INTENTIONAL UNDERDOSE 3 0.0004
488 POLLAKIURIA 17 0.0004
489 VITREOUS FLOATERS 4 0.0004
490 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
491 MUSCLE SPASMS 74 0.0004
492 INJECTION SITE INFLAMMATION 2 0.0004
493 APHASIA 12 0.0004
494 VISION BLURRED 54 0.0004
495 TOOTH ABSCESS 4 0.0004
496 BODY TEMPERATURE INCREASED 8 0.0004
497 LIPASE INCREASED 3 0.0004
498 VIRAL INFECTION 13 0.0004
499 EAR DISCOMFORT 4 0.0004
500 UNRESPONSIVE TO STIMULI 10 0.0004
501 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
502 OEDEMA 21 0.0004
503 APHTHOUS ULCER 3 0.0004
504 PELVIC FRACTURE 3 0.0004
505 EYE DISCHARGE 4 0.0004
506 RESTLESS LEGS SYNDROME 7 0.0004
507 RESPIRATORY FAILURE 28 0.0004
508 DYSURIA 14 0.0004
509 ANAPHYLACTIC REACTION 21 0.0004
510 FOOD CRAVING 2 0.0004
511 NEUROPATHY PERIPHERAL 36 0.0004
512 INCONTINENCE 4 0.0004
513 RENAL CYST 3 0.0004
514 RENAL PAIN 4 0.0004
515 SCIATICA 6 0.0004
516 ABSCESS 6 0.0004
517 BACTERIAL INFECTION 7 0.0004
518 NEOPLASM MALIGNANT 25 0.0004
519 UTERINE CANCER 3 0.0004
520 MALIGNANT MELANOMA 5 0.0004
521 HEREDITARY ANGIOEDEMA 4 0.0004
522 QUALITY OF LIFE DECREASED 5 0.0004
523 BRUXISM 2 0.0004
524 COUGH 104 0.0004
525 MUSCLE DISORDER 3 0.0004
526 HEART RATE DECREASED 13 0.0004
527 PRESYNCOPE 9 0.0004
528 SINUS CONGESTION 5 0.0004
529 PHARYNGITIS STREPTOCOCCAL 4 0.0004
530 FOOT FRACTURE 7 0.0004
531 BLOOD URINE PRESENT 7 0.0004
532 SEPTIC SHOCK 16 0.0004
533 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
534 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
535 WOUND INFECTION 4 0.0004
536 GLAUCOMA 7 0.0004
537 PHOTOSENSITIVITY REACTION 6 0.0004
538 CHOKING SENSATION 2 0.0004
539 VERTIGO 22 0.0004
540 PROCEDURAL PAIN 10 0.0004
541 THROMBOSIS 29 0.0004
542 PRODUCT DOSE OMISSION ISSUE 106 0.0004
543 HEART RATE ABNORMAL 2 0.0004
544 THROAT IRRITATION 16 0.0004
545 OROPHARYNGEAL PAIN 33 0.0004
546 SENSATION OF FOREIGN BODY 3 0.0004
547 RHINORRHOEA 23 0.0004
548 GAIT DISTURBANCE 68 0.0004
549 EYE INFECTION 4 0.0004
550 PAIN IN JAW 10 0.0004
551 CHOLECYSTITIS ACUTE 2 0.0004
552 DIALYSIS 5 0.0004
553 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
554 PRODUCT AVAILABILITY ISSUE 8 0.0004
555 CARDIAC VALVE DISEASE 2 0.0003
556 NEOPLASM 4 0.0003
557 IMPAIRED QUALITY OF LIFE 5 0.0003
558 HYPOAESTHESIA 52 0.0003
559 PARAESTHESIA ORAL 5 0.0003
560 ENTEROCOLITIS 2 0.0003
561 HYPOKINESIA 5 0.0003
562 ELECTROLYTE IMBALANCE 4 0.0003
563 CHILLS 40 0.0003
564 DIABETES MELLITUS 26 0.0003
565 EAR INFECTION 9 0.0003
566 ATAXIA 4 0.0003
567 FACIAL PAIN 3 0.0003
568 CEREBRAL HAEMORRHAGE 12 0.0003
569 MACULAR DEGENERATION 4 0.0003
570 POLYNEUROPATHY 4 0.0003
571 WRIST FRACTURE 4 0.0003
572 HEADACHE 209 0.0003
573 THYROID CANCER 4 0.0003
574 CHEST DISCOMFORT 34 0.0003
575 GANGRENE 2 0.0003
576 LEUKOCYTOSIS 6 0.0003
577 INJECTION SITE VESICLES 2 0.0003
578 BURSITIS 4 0.0003
579 URINARY RETENTION 11 0.0003
580 EXOSTOSIS 3 0.0003
581 INCREASED TENDENCY TO BRUISE 3 0.0003
582 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
583 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
584 POOR QUALITY SLEEP 7 0.0003
585 HEPATIC STEATOSIS 6 0.0003
586 WOUND 9 0.0003
587 APPENDICITIS 3 0.0003
588 SWOLLEN TONGUE 10 0.0003
589 FLANK PAIN 3 0.0003
590 MYALGIA 54 0.0003
591 FRACTURE 6 0.0003
592 SPINAL DISORDER 3 0.0003
593 LUNG NEOPLASM MALIGNANT 13 0.0003
594 DEHYDRATION 42 0.0003
595 FEELING JITTERY 6 0.0003
596 VISUAL IMPAIRMENT 39 0.0003
597 ANGINA PECTORIS 9 0.0003
598 TREMOR 52 0.0003
599 INTRAOCULAR PRESSURE INCREASED 4 0.0003
600 SNEEZING 7 0.0003
601 ACUTE RESPIRATORY FAILURE 6 0.0003
602 ROAD TRAFFIC ACCIDENT 13 0.0003
603 DIZZINESS POSTURAL 3 0.0003
604 BLOOD POTASSIUM INCREASED 5 0.0003
605 MALAISE 135 0.0003
606 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
607 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
608 MOBILITY DECREASED 22 0.0003
609 ACUTE MYOCARDIAL INFARCTION 9 0.0003
610 JOINT STIFFNESS 8 0.0003
611 SKIN DISCOLOURATION 14 0.0003
612 ORAL CANDIDIASIS 4 0.0003
613 LIGAMENT SPRAIN 3 0.0003
614 BLADDER DISORDER 3 0.0003
615 ADVERSE REACTION 4 0.0003
616 EYE PAIN 17 0.0003
617 FUNGAL INFECTION 10 0.0003
618 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
619 INJECTION SITE PRURITUS 20 0.0003
620 GENERAL PHYSICAL HEALTH DETERIORATION 34 0.0003
621 IMPAIRED GASTRIC EMPTYING 4 0.0003
622 NEUTROPHIL COUNT INCREASED 3 0.0003
623 HEART RATE INCREASED 29 0.0003
624 PERIPHERAL COLDNESS 4 0.0003
625 UNEVALUABLE EVENT 22 0.0003
626 VENTRICULAR EXTRASYSTOLES 3 0.0003
627 PAIN IN EXTREMITY 85 0.0003
628 FEELING COLD 8 0.0003
629 METASTASES TO LIVER 5 0.0003
630 PULMONARY EMBOLISM 27 0.0003
631 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
632 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
633 DIVERTICULUM 2 0.0003
634 LOSS OF CONSCIOUSNESS 36 0.0003
635 FEELING ABNORMAL 67 0.0003
636 OSTEOMYELITIS 5 0.0003
637 CARDIAC FAILURE CONGESTIVE 22 0.0003
638 RENAL IMPAIRMENT 23 0.0003
639 BLOOD GLUCOSE FLUCTUATION 3 0.0003
640 BLINDNESS TRANSIENT 2 0.0003
641 SKIN ULCER 7 0.0003
642 FOOT DEFORMITY 3 0.0003
643 HAEMATOMA 7 0.0003
644 TRANSAMINASES INCREASED 6 0.0003
645 FEELING DRUNK 2 0.0003
646 OCULAR DISCOMFORT 3 0.0003
647 INJECTION SITE ERYTHEMA 33 0.0003
648 BLOOD SODIUM DECREASED 5 0.0003
649 PANCREATITIS 14 0.0003
650 CHEST PAIN 49 0.0003
651 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
652 MIGRAINE 25 0.0003
653 EPILEPSY 8 0.0003
654 PARAESTHESIA 41 0.0003
655 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
656 DELIRIUM 9 0.0003
657 ATRIOVENTRICULAR BLOCK 2 0.0003
658 RASH MACULAR 9 0.0003
659 CARDIAC DISORDER 24 0.0003
660 ORAL HERPES 5 0.0003
661 SKIN LESION 7 0.0003
662 INFLUENZA LIKE ILLNESS 21 0.0003
663 SINUS DISORDER 5 0.0003
664 FURUNCLE 2 0.0003
665 CHOLECYSTITIS 3 0.0003
666 GINGIVAL PAIN 2 0.0003
667 BLOOD PRESSURE FLUCTUATION 6 0.0002
668 BLOOD DISORDER 2 0.0002
669 CARDIAC FAILURE 20 0.0002
670 NOCTURIA 3 0.0002
671 SWELLING FACE 16 0.0002
672 ARTHRALGIA 102 0.0002
673 ASPHYXIA 2 0.0002
674 ENCEPHALOPATHY 6 0.0002
675 HICCUPS 2 0.0002
676 HYPERAESTHESIA 2 0.0002
677 ESCHERICHIA INFECTION 2 0.0002
678 OSTEOPOROSIS 10 0.0002
679 TENDON RUPTURE 3 0.0002
680 DEATH 208 0.0002
681 WEIGHT INCREASED 54 0.0002
682 EMBOLISM 2 0.0002
683 CYTOMEGALOVIRUS INFECTION 4 0.0002
684 HEMIPLEGIA 2 0.0002
685 WEIGHT DECREASED 67 0.0002
686 PEMPHIGUS 3 0.0002
687 SKIN DISORDER 8 0.0002
688 INJECTION SITE BRUISING 19 0.0002
689 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
690 INFUSION SITE ERYTHEMA 2 0.0002
691 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
692 CANDIDA INFECTION 4 0.0002
693 HALLUCINATION, VISUAL 5 0.0002
694 PROSTATE CANCER 19 0.0002
695 FLUID RETENTION 12 0.0002
696 IMPAIRED WORK ABILITY 5 0.0002
697 ERECTILE DYSFUNCTION 6 0.0002
698 HEPATIC FAILURE 7 0.0002
699 BLOOD MAGNESIUM DECREASED 2 0.0002
700 DISEASE RECURRENCE 11 0.0002
701 CARDIAC MURMUR 2 0.0002
702 SOMNOLENCE 46 0.0002
703 GROIN PAIN 2 0.0002
704 DIARRHOEA 146 0.0002
705 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
706 DRUG ERUPTION 4 0.0002
707 BREAST CANCER FEMALE 6 0.0002
708 GALLBLADDER DISORDER 4 0.0002
709 HAEMOLYTIC ANAEMIA 2 0.0002
710 GOUT 4 0.0002
711 ADVERSE DRUG REACTION 20 0.0002
712 CHROMATURIA 5 0.0002
713 TOOTHACHE 4 0.0002
714 TACHYPNOEA 3 0.0002
715 ANAEMIA 42 0.0002
716 C-REACTIVE PROTEIN INCREASED 8 0.0002
717 DIZZINESS 109 0.0002
718 INJECTION SITE REACTION 15 0.0002
719 BRAIN NEOPLASM 2 0.0002
720 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
721 BLOOD GLUCOSE ABNORMAL 4 0.0002
722 ARTHRITIS 17 0.0002
723 COORDINATION ABNORMAL 3 0.0002
724 EYE SWELLING 8 0.0002
725 COGNITIVE DISORDER 10 0.0002
726 IMPAIRED HEALING 7 0.0002
727 OSTEONECROSIS 7 0.0002
728 HEPATIC CIRRHOSIS 4 0.0002
729 OFF LABEL USE 186 0.0002
730 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
731 COLITIS 8 0.0002
732 PYREXIA 73 0.0002
733 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
734 MUSCULOSKELETAL PAIN 11 0.0002
735 SYNCOPE 21 0.0002
736 RED BLOOD CELL COUNT DECREASED 6 0.0002
737 PULMONARY FIBROSIS 4 0.0002
738 BLOOD GLUCOSE DECREASED 10 0.0002
739 DIABETIC KETOACIDOSIS 5 0.0002
740 HEPATIC CANCER 5 0.0002
741 INJECTION SITE HAEMATOMA 3 0.0002
742 FLUSHING 21 0.0002
743 NEEDLE ISSUE 6 0.0002
744 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
745 DISORIENTATION 8 0.0002
746 INABILITY TO AFFORD MEDICATION 2 0.0002
747 COLON CANCER 3 0.0002
748 HYPOTONIA 2 0.0002
749 BURNING SENSATION 14 0.0002
750 SLEEP DISORDER 14 0.0002
751 NAUSEA 155 0.0002
752 INJECTION SITE SWELLING 15 0.0002
753 FEELING HOT 12 0.0002
754 MYOCARDIAL INFARCTION 34 0.0002
755 THYROID DISORDER 3 0.0002
756 HYPERHIDROSIS 25 0.0002
757 MENINGIOMA 3 0.0002
758 HYPERGLYCAEMIA 7 0.0002
759 LETHARGY 11 0.0002
760 ECZEMA 10 0.0002
761 ARRHYTHMIA 9 0.0002
762 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
763 HALLUCINATION, AUDITORY 3 0.0002
764 RASH ERYTHEMATOUS 9 0.0002
765 HYPOTHYROIDISM 6 0.0002
766 INSOMNIA 50 0.0002
767 LIVER FUNCTION TEST INCREASED 4 0.0002
768 NIGHT SWEATS 6 0.0002
769 DRUG INEFFECTIVE 245 0.0002
770 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
771 MENTAL DISORDER 8 0.0002
772 MUSCULOSKELETAL STIFFNESS 16 0.0002
773 HAEMATOCHEZIA 10 0.0002
774 DENTAL CARIES 2 0.0002
775 HYPERTENSION 38 0.0002
776 DEMENTIA 5 0.0002
777 TYPE 2 DIABETES MELLITUS 6 0.0002
778 FISTULA 2 0.0002
779 BLOOD CALCIUM DECREASED 2 0.0002
780 HEART RATE IRREGULAR 4 0.0002
781 ASTHMA 20 0.0002
782 PAIN 108 0.0002
783 DEPRESSION 40 0.0002
784 SWELLING 16 0.0002
785 HYPOXIA 6 0.0002
786 DEPRESSED MOOD 9 0.0002
787 LYMPHOCYTE COUNT DECREASED 3 0.0002
788 BRADYCARDIA 9 0.0002
789 HYPOTENSION 34 0.0002
790 PLATELET COUNT DECREASED 18 0.0002
791 TACHYCARDIA 15 0.0002
792 WHEEZING 10 0.0002
793 ABDOMINAL PAIN 39 0.0002
794 ACCIDENT 2 0.0002
795 BLOOD POTASSIUM DECREASED 5 0.0002
796 PANIC ATTACK 6 0.0002
797 FIBROMYALGIA 4 0.0002
798 INJECTION SITE EXTRAVASATION 2 0.0002
799 CONJUNCTIVITIS 3 0.0002
800 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
801 ILEUS 2 0.0002
802 AGEUSIA 4 0.0002
803 DRY EYE 8 0.0002
804 DECREASED APPETITE 37 0.0002
805 DERMATITIS ALLERGIC 2 0.0002
806 LIVER DISORDER 7 0.0002
807 GASTRIC ULCER 3 0.0002
808 CARDIOVASCULAR DISORDER 4 0.0002
809 INJECTION SITE IRRITATION 2 0.0002
810 EYE IRRITATION 9 0.0002
811 GASTROINTESTINAL DISORDER 14 0.0002
812 HYPERSENSITIVITY 29 0.0002
813 ANAPHYLACTIC SHOCK 4 0.0002
814 ABDOMINAL DISCOMFORT 26 0.0002
815 DEEP VEIN THROMBOSIS 10 0.0002
816 HAEMORRHOIDS 3 0.0002
817 ABDOMINAL DISTENSION 16 0.0002
818 CHOLELITHIASIS 5 0.0002
819 DISABILITY 3 0.0002
820 ANXIETY 43 0.0002
821 DYSMENORRHOEA 2 0.0002
822 RENAL DISORDER 7 0.0002
823 EYE HAEMORRHAGE 2 0.0001
824 PRODUCT PHYSICAL ISSUE 3 0.0001
825 TASTE DISORDER 3 0.0001
826 RASH PRURITIC 8 0.0001
827 CEREBROVASCULAR ACCIDENT 25 0.0001
828 INJECTION SITE PAIN 45 0.0001
829 CORONARY ARTERY OCCLUSION 2 0.0001
830 CARDIAC ARREST 12 0.0001
831 PERITONITIS 3 0.0001
832 HYPOGLYCAEMIA 7 0.0001
833 LUNG DISORDER 7 0.0001
834 CARPAL TUNNEL SYNDROME 2 0.0001
835 BLISTER 8 0.0001
836 BLOOD TEST ABNORMAL 2 0.0001
837 CONFUSIONAL STATE 23 0.0001
838 BLINDNESS UNILATERAL 2 0.0001
839 LYMPHADENOPATHY 5 0.0001
840 BRONCHOSPASM 2 0.0001
841 RECTAL HAEMORRHAGE 6 0.0001
842 OEDEMA PERIPHERAL 17 0.0001
843 PANCREATIC CARCINOMA 4 0.0001
844 FAECES DISCOLOURED 3 0.0001
845 HYPERTHYROIDISM 2 0.0001
846 PRODUCT DISPENSING ERROR 3 0.0001
847 LABORATORY TEST ABNORMAL 4 0.0001
848 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
849 PULMONARY OEDEMA 6 0.0001
850 PANCREATITIS ACUTE 3 0.0001
851 HOT FLUSH 10 0.0001
852 INTESTINAL OBSTRUCTION 5 0.0001
853 HEPATIC ENZYME INCREASED 9 0.0001
854 VOMITING 62 0.0001
855 CHRONIC KIDNEY DISEASE 10 0.0001
856 ABDOMINAL PAIN UPPER 27 0.0001
857 DISCOMFORT 8 0.0001
858 SKIN EXFOLIATION 11 0.0001
859 SEIZURE 15 0.0001
860 FEMUR FRACTURE 4 0.0001
861 BREAST CANCER 12 0.0001
862 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
863 EJECTION FRACTION DECREASED 2 0.0001
864 PLASMA CELL MYELOMA 5 0.0001
865 TREATMENT NONCOMPLIANCE 7 0.0001
866 CYANOSIS 2 0.0001
867 ABNORMAL BEHAVIOUR 5 0.0001
868 COMA 6 0.0001
869 PRODUCT STORAGE ERROR 11 0.0001
870 HAEMORRHAGE 13 0.0001
871 MENTAL IMPAIRMENT 3 0.0001
872 NEURALGIA 3 0.0001
873 UNDERDOSE 9 0.0001
874 DRY MOUTH 10 0.0001
875 PSORIATIC ARTHROPATHY 5 0.0001
876 DYSKINESIA 5 0.0001
877 INJECTION SITE URTICARIA 3 0.0001
878 ALOPECIA 24 0.0001
879 ERYTHEMA 25 0.0001
880 DEVICE DIFFICULT TO USE 8 0.0001
881 EPISTAXIS 9 0.0001
882 COAGULOPATHY 2 0.0001
883 DRUG INTERACTION 19 0.0001
884 BLOOD UREA INCREASED 2 0.0001
885 EYE PRURITUS 4 0.0001
886 BLADDER CANCER 7 0.0001
887 FACE OEDEMA 2 0.0001
888 CIRCULATORY COLLAPSE 2 0.0001
889 HAEMOGLOBIN DECREASED 12 0.0001
890 DRUG RESISTANCE 3 0.0001
891 MEMORY IMPAIRMENT 16 0.0001
892 VAGINAL HAEMORRHAGE 5 0.0001
893 NERVOUSNESS 6 0.0001
894 DEAFNESS 3 0.0001
895 PRURITUS 44 0.0001
896 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
897 FREQUENT BOWEL MOVEMENTS 3 0.0001
898 PALPITATIONS 13 0.0001
899 PALLOR 3 0.0001
900 RESTLESSNESS 4 0.0001
901 HYPOKALAEMIA 5 0.0001
902 JOINT SWELLING 13 0.0001
903 BLOOD CREATININE INCREASED 7 0.0001
904 HEPATIC FUNCTION ABNORMAL 4 0.0001
905 INCREASED APPETITE 2 0.0001
906 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
907 RASH 45 0.0001
908 DYSTONIA 2 0.0001
909 BONE PAIN 6 0.0001
910 DEVICE ISSUE 9 0.0001
911 EMOTIONAL DISTRESS 12 0.0001
912 CORONARY ARTERY DISEASE 3 0.0001
913 BLINDNESS 4 0.0001
914 INJECTION SITE WARMTH 2 0.0001
915 EXPOSURE DURING PREGNANCY 6 0.0001
916 NERVOUS SYSTEM DISORDER 3 0.0001
917 DRUG-INDUCED LIVER INJURY 3 0.0001
918 DYSGEUSIA 7 0.0001
919 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
920 HYPOACUSIS 4 0.0001
921 DEVICE LEAKAGE 4 0.0001
922 DEVICE DISLOCATION 4 0.0001
923 INCORRECT DOSE ADMINISTERED 21 0.0001
924 ANGIOEDEMA 4 0.0001
925 RENAL FAILURE 12 0.0001
926 LIP SWELLING 3 0.0001
927 ARTHROPATHY 5 0.0001
928 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
929 URTICARIA 15 0.0001
930 GLOSSODYNIA 2 0.0001
931 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
932 ANGER 3 0.0001
933 FLATULENCE 5 0.0001
934 NIGHTMARE 3 0.0001
935 BLOOD CHOLESTEROL INCREASED 4 0.0001
936 HYPERKALAEMIA 3 0.0001
937 TREATMENT FAILURE 7 0.0001
938 RENAL CANCER 4 0.0001
939 MYELOSUPPRESSION 3 0.0001
940 PLEURAL EFFUSION 5 0.0001
941 AGITATION 6 0.0001
942 INJECTION SITE MASS 3 0.0001
943 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
944 HALLUCINATION 6 0.0001
945 RHEUMATOID ARTHRITIS 9 0.0001
946 HYPOPHAGIA 2 0.0001
947 DISEASE PROGRESSION 9 0.0001
948 GASTRITIS 2 0.0001
949 DISTURBANCE IN ATTENTION 4 0.0001
950 BLOOD BILIRUBIN INCREASED 2 0.0001
951 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
952 NEUTROPHIL COUNT DECREASED 3 0.0001
953 CONSTIPATION 16 0.0001
954 ABNORMAL DREAMS 2 0.0001
955 HAEMOPTYSIS 2 0.0001
956 OSTEOARTHRITIS 3 0.0001
957 SKIN BURNING SENSATION 5 0.0001
958 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
959 ASCITES 2 0.0001
960 TINNITUS 3 0.0001
961 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
962 OCULAR HYPERAEMIA 3 0.0001
963 INTERSTITIAL LUNG DISEASE 3 0.0001
964 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
965 AMNESIA 4 0.0001
966 ACUTE KIDNEY INJURY 9 0.0001
967 HAEMATURIA 2 0.0001
968 BLOOD GLUCOSE INCREASED 11 0.0001
969 CRYING 2 0.0001
970 ACCIDENTAL OVERDOSE 2 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
972 ADVERSE EVENT 5 0.0001
973 PANCYTOPENIA 3 0.0001
974 PSORIASIS 7 0.0001
975 DRY SKIN 7 0.0001
976 DRUG INTOLERANCE 5 0.0001
977 NO ADVERSE EVENT 9 0.0000
978 NEUTROPENIA 6 0.0000
979 DEVICE MALFUNCTION 3 0.0000
980 PRODUCT USE ISSUE 8 0.0000
981 DYSPEPSIA 4 0.0000
982 ACNE 3 0.0000
983 INFLAMMATION 2 0.0000
984 INJECTION SITE HAEMORRHAGE 3 0.0000
985 THROMBOCYTOPENIA 4 0.0000
986 COMPLETED SUICIDE 2 0.0000
987 OVERDOSE 5 0.0000
988 DRUG WITHDRAWAL SYNDROME 2 0.0000
989 DRUG DEPENDENCE 2 0.0000